Literature DB >> 29913715

Repeated sinomenine administration alleviates chronic neuropathic pain-like behaviours in rodents without producing tolerance.

Tianle Gao1, Tiansheng Shi1, Dan-Qiao Wang2, Zsuzsanna Wiesenfeld-Hallin1, Xiao-Jun Xu1.   

Abstract

Background and aims We have previously reported that systemic administration of sinomenine produced antinociception in various experimental pain conditions in rodents, particularly in models of neuropathic pain. In the present study we assessed the effects of repeated administration of sinomenine in two rodent models of neuropathic pain in order to study the development of tolerance. Methods The analgesic effect of sinomenine was tested in female Sprague-Dawley rats that exhibited mechanical and cold hypersensitivity following ischaemic injury to the spinal cord and in male C57/BL6 mice that developed mechanical hypersensitivity after ischaemic injury to the sciatic nerve. Briefly, the animals were anaesthetized and injected i.v. with the photosensitizing dye erythrosine B. Vertebral segments T12 to T13 in rats or the sciatic nerve in mice were exposed and irradiated under an argon ion laser for 10min or 45s, respectively. In rats, mechanical hypersensitivity to pressure with von Frey hairs, the response to brushing and decreasing cold temperature were tested in the flanks or upper back areas. In mice, mechanical hypersensitivity on the hind paw to von Frey hairs and response to cold following a drop of acetone were measured. Sinomenine was administered i.p. in rats and p.o. in mice at 10:00 and 16:00, twice a day for 5 days. Response threshold before and 2h after drug administration at 10.00h was recorded. Results Repeated administration of sinomenine at 10 or 20mg/kg twice a day, doses that have no analgesic effect as single injection, alleviated mechanical, but not cold allodynia in spinally injured rats and the effect was maintained during the 5 day treatment period with no signs of tolerance. Furthermore, the pre-drug response threshold was significantly elevated during repeated treatment with 20mg/kg sinomenine. Sinomenine administered at 40mg/kg twice a day for 5 days significantly reduced mechanical and cold alldoynia, elevated pre-drug response threshold without tolerance development in spinally injured rats. Similarly, sinomenine at 80mg/kg twice a day for 5 days significantly reduced mechanical allodynia in mice with sciatic nerve injury and increased pre-drug response threshold with no sign of tolerance. The effect of sinomenine on response threshold persisted for days after termination of the 5 day drug administration. Conclusions The results suggest that repeated administration of simomenine produced an enhanced anti-allodynic effect without tolerance in rodent models of neuropathic pain. Implications Sinomenine may be tested as a novel analgesic in treating some forms of chronic neuropathic pain in patients.

Entities:  

Keywords:  Neuropathic pain; Sciatic nerveinjury; Sinomenine; Spinal cord injury; Tolerance

Year:  2014        PMID: 29913715     DOI: 10.1016/j.sjpain.2014.05.006

Source DB:  PubMed          Journal:  Scand J Pain        ISSN: 1877-8860


  10 in total

1.  Sinomenine Confers Protection Against Myocardial Ischemia Reperfusion Injury by Preventing Oxidative Stress, Cellular Apoptosis, and Inflammation.

Authors:  Boyu Xia; Qi Li; Jingjing Wu; Xiaomei Yuan; Fei Wang; Xu Lu; Chao Huang; Koulong Zheng; Rongrong Yang; Le Yin; Kun Liu; Qingsheng You
Journal:  Front Pharmacol       Date:  2022-06-28       Impact factor: 5.988

2.  Anti-breast cancer sinomenine derivatives via mechanisms of apoptosis induction and metastasis reduction.

Authors:  Xiang Gao; Baojia Sun; Yonglian Hou; Lilin Liu; Jianan Sun; Fanxing Xu; Dahong Li; Huiming Hua
Journal:  J Enzyme Inhib Med Chem       Date:  2022-12       Impact factor: 5.756

Review 3.  Analgesic Alkaloids Derived From Traditional Chinese Medicine in Pain Management.

Authors:  Wei Jiang; Mingze Tang; Limin Yang; Xu Zhao; Jun Gao; Yue Jiao; Tao Li; Cai Tie; Tianle Gao; Yanxing Han; Jian-Dong Jiang
Journal:  Front Pharmacol       Date:  2022-05-10       Impact factor: 5.988

Review 4.  Targeting P2 receptors in purinergic signaling: a new strategy of active ingredients in traditional Chinese herbals for diseases treatment.

Authors:  Xiaopeng Ai; Xing Dong; Ying Guo; Peng Yang; Ya Hou; Jinrong Bai; Sanyin Zhang; Xiaobo Wang
Journal:  Purinergic Signal       Date:  2021-03-22       Impact factor: 3.765

5.  Antinociceptive effects of sinomenine in a rat model of neuropathic pain.

Authors:  Qing Zhu; Yuehua Sun; Jie Zhu; Tian Fang; Wei Zhang; Jun-Xu Li
Journal:  Sci Rep       Date:  2014-12-01       Impact factor: 4.379

Review 6.  Analgesic Mechanism of Sinomenine against Chronic Pain.

Authors:  Wei Jiang; Weiming Fan; Tianle Gao; Tao Li; Zhenming Yin; Huihui Guo; Lulu Wang; Yanxing Han; Jian-Dong Jiang
Journal:  Pain Res Manag       Date:  2020-05-06       Impact factor: 3.037

7.  Protective Effects of Konjac and Inulin Extracts on Type 1 and Type 2 Diabetes.

Authors:  Tianle Gao; Yue Jiao; Yang Liu; Tao Li; Zhiguo Wang; Danqiao Wang
Journal:  J Diabetes Res       Date:  2019-10-07       Impact factor: 4.011

8.  Antinociceptive Effects of Sinomenine Combined With Ligustrazine or Paracetamol in Animal Models of Incisional and Inflammatory Pain.

Authors:  Tianle Gao; Tao Li; Wei Jiang; Weiming Fan; Xiao-Jun Xu; Xiaoliang Zhao; Zhenming Yin; Huihui Guo; Lulu Wang; Jun Gao; Yanxing Han; Jian-Dong Jiang; Danqiao Wang
Journal:  Front Physiol       Date:  2021-02-09       Impact factor: 4.566

9.  RIP3 Inhibition ameliorates chronic constriction injury-induced neuropathic pain by suppressing JNK signaling.

Authors:  Na He; Yu-Juan Qu; Dan-Yang Li; Shou-Wei Yue
Journal:  Aging (Albany NY)       Date:  2021-11-12       Impact factor: 5.682

10.  Exploratory study data for determining the adverse effects of sinomenine plus gabapentin or ligustrazine hydrochloride and the pharmacokinetic insights of sinomenine in plasma and CNS tissue.

Authors:  Tianle Gao; Tao Li; Wei Jiang; Weiming Fan; Jian-Dong Jiang
Journal:  Data Brief       Date:  2019-10-08
  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.